Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSALV.L Regulatory News (SALV)

  • There is currently no data for SALV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notifications of Transfers of Shares

4 Oct 2011 11:32

RNS Number : 5172P
3Legs Resources plc
04 October 2011
 



4 October 2011

 

 

3Legs Resources plc

 

 

Notifications of Transfers of Shares: No Change in Beneficial Ownership

 

3Legs Resources plc (the "Company") has received notice of certain transfers of ordinary shares in the Company made or to be made by or on behalf of Robert Jeffcock, a Non-Executive Director, William Jeffcock (the son of Robert Jeffcock) and Kamlesh Parmar, Commercial Director and Poland Country Manager, to nominee accounts solely for administrative purposes and, in the case of Kamlesh Parmar, for pension planning purposes as well. Details of the transfers, which involve no change in beneficial ownership and have been approved by the Company's Nomad, are as follows:

 

1. 5,921,608 ordinary shares, representing approximately 6.98 per cent of the issued share capital of the Company, have been transferred for administrative purposes only by Caithness Limited, acting as trustee for Robert Jeffcock, into a nominee account through a transfer into the name of Vidacos Nominees Limited. Caithness Limited continues to hold as trustee for Robert Jeffcock a further 1,480,400 ordinary shares, representing approximately 1.75 per cent of the issued share capital of the Company.

 

2. 8,709,352 ordinary shares, representing approximately 10.27 per cent of the issued share capital of the Company, have been transferred for administrative purposes only by Tomuro Limited, acting as trustee for William Jeffcock, into a nominee account through a transfer into the name of Lynchwood Nominees Limited. William Jeffcock continues to hold under his own name a further 120,000 ordinary shares, representing approximately 0.14 per cent of the issued share capital of the Company.

 

3. 3,346,833 ordinary shares, representing approximately 3.95 per cent of the issued share capital of the Company, will shortly be transferred for administrative purposes only by Kamlesh Parmar into a nominee account through a transfer into the name of Ferlim Nominees Limited. A further 52,083 ordinary shares, representing approximately 0.06 per cent of the issued share capital of the Company, will shortly be transferred by Kamlesh Parmar into his self-invested personal pension plan, through a transfer into the name of Ferlim Nominees Limited. In aggregate, Kamlesh Parmar is transferring 3,398,916 ordinary shares to nominee accounts representing approximately 4.01 per cent of the issued share capital of the Company.

 

The above transfers do not result in any change in beneficial ownership, although they involve technical changes in legal ownership which are required to be disclosed under AIM Rules For Companies. All of the ordinary shares which are the subject of the transfers described above remain subject to the one year lock-up restrictions agreed by Caithness Limited acting as trustee for Robert Jeffcock, Tomuro Limited acting as trustee for William Jeffcock, and Kamlesh Parmar, amongst others, in connection with the Company's listing on AIM completed on 14 June 2011. Neither Vidacos Nominees Limited, Lynchwood Nominees Limited nor Ferlim Nominees Limited will have any discretion to act in relation to any of the ordinary shares referred to above, including voting on any Company matters, without prior instruction from Robert Jeffcock, in the case of Vidacos Nominees Limited, William Jeffcock, in the case of Lynchwood Nominees Limited or Kamlesh Parmar, in the case of Ferlim Nominees Limited.

 

The above transfers will be concluded by 6 October 2011.

 

 

For further information please contact:

 

3Legs Resources plc

Tel:

+44 1624 811 611

Peter Clutterbuck, Chief Executive Officer

Alexander Fraser, Chief Financial Officer

Jefferies International Limited

Tel:

+44 207 029 8000

Chris Snoxall

Alex Grant

College Hill

Tel:

+44 207 457 2020

Nick Elwes

Catherine Maitland

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBZLFBFBFXFBF
Date   Source Headline
9th Jan 20202:30 pmRNSCancellation of trading on AIM
20th Dec 201910:30 amRNSCancellation of AIM listing /Potential acquisition
27th Sep 201911:07 amRNSHalf-year Report - Correction
26th Sep 20192:06 pmRNSHalf-year Report
23rd Sep 20193:02 pmRNSAIM Rule 17 Notification
9th Jul 20197:30 amRNSSuspension - SalvaRx Group Plc
9th Jul 20197:30 amRNSSuspension of Trading
28th Jun 201911:26 amRNSFinal Results
31st Jan 20197:00 amRNSChange of Nominated Adviser and Broker
17th Jan 20192:05 pmRNSSecond Price Monitoring Extn
17th Jan 20192:00 pmRNSPrice Monitoring Extension
8th Jan 20194:15 pmRNSResult of AGM and Completion of Disposal
4th Jan 20195:30 pmRNSSalvarx Group
14th Dec 20187:50 amRNSNominated Adviser Status
10th Dec 20187:00 amRNSIssue of US$1 million of Loan Notes by iOx
27th Nov 20187:00 amRNSPosting of Circular and Notice of AGM
21st Nov 20181:00 pmRNSTransaction Update
6th Nov 20187:00 amRNSDirector/PDMR Dealing
22nd Oct 20189:47 amRNSIntensity Therapeutics Update
9th Oct 20187:00 amRNSExercise of Warrants
27th Sep 20187:00 amRNSHalf-year Report
28th Aug 20185:40 pmRNSUpdate re proposed disposal and demerger
14th Aug 20187:00 amRNSProposed disposal of interest in SalvaRx Limited
1st Aug 20184:40 pmRNSSecond Price Monitoring Extn
1st Aug 20184:35 pmRNSPrice Monitoring Extension
23rd Jul 20181:17 pmRNSDelay in iOx development programme
28th Jun 20187:00 amRNSFinal Results
26th Jun 20187:00 amRNSRelated Party Loan of US$1 million
8th Mar 201812:00 pmRNSDrug Pipeline Progress and iOx Loan Note Issue
30th Oct 20174:40 pmRNSSecond Price Monitoring Extn
30th Oct 20174:35 pmRNSPrice Monitoring Extension
23rd Oct 20177:00 amRNSSubscriptions for SalvaRx Ltd Loan Facility
27th Sep 20179:00 amRNSHalf-year Report
25th Sep 20178:00 amRNSFormation of Saugatuck Therapeutics
1st Aug 20173:30 pmRNSHolding(s) in Company
1st Aug 20173:30 pmRNSHolding(s) in Company
31st Jul 20171:45 pmRNSResult of AGM
5th Jul 20173:03 pmRNSNotice of AGM
30th Jun 20178:34 amRNSFinal Results
30th May 201712:45 pmRNSIntensity Therapeutics Treats First Patient
20th Mar 20177:00 amRNSInvestment in Rift Biotherapeutics
2nd Mar 20177:00 amRNSRestructuring, Loan Conversion and Loan Facility
28th Feb 20177:00 amRNSInvestment in Nekonal
2nd Feb 20174:37 pmRNSIntensity Therapeutics
3rd Oct 20164:40 pmRNSSecond Price Monitoring Extn
3rd Oct 20164:35 pmRNSPrice Monitoring Extension
14th Sep 20167:00 amRNSCorporate Video
13th Sep 20167:00 amRNSHalf-year Report
22nd Aug 20167:00 amRNSDrug Pipeline Progress including Patent Grants
4th Aug 20162:05 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.